IWP iShares Russell Mid-Cap Growth ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| HWM | 3.35% |
| VRT | 3.34% |
| HLT | 2.54% |
| RCL | 2.49% |
| PWR | 2.29% |
| NET | 2.29% |
| COR | 2.13% |
| TRGP | 1.97% |
| VST | 1.87% |
| MPWR | 1.74% |
ETF Analysis
Fund Overview
iShares Russell Mid-Cap Growth ETF (IWP) currently reports 276 stock positions (subject to change), placing it in the broadly diversified range by holdings breadth. The top line-up is HWM (3.35%), VRT (3.34%), HLT (2.54%), with HWM as the largest single weight at 3.35%. Together, the top three holdings account for 9.23%, which indicates that performance drivers are distributed more evenly across the broader basket. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.
Profitability & Capital Efficiency
From a capital efficiency perspective, ROIC is 25.97%, WACC is 10.36%, and the economic spread is 15.61%. On balance, holdings generate meaningful returns above their cost of capital, a hallmark of competitively advantaged businesses. Supporting metrics show ROE at 29.41% and ROA at 7.30%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
Valuation currently screens at trailing P/E of 29.29, forward P/E of 22.89, PEG of 1.86. Trailing and forward multiples are somewhat apart, indicating the market is pricing measured earnings growth without aggressive expansion assumptions. Growth-adjusted valuation is in a reasonable range, with the multiple broadly in line with expected earnings expansion. At 2.14, the aggregate current ratio indicates adequate but not exceptional balance sheet coverage. The valuation profile here is neither obviously cheap nor dramatically expensive — a setup where the return case is built more on earnings delivery than on re-rating potential.
Margins & Cash Generation
On the margin front: gross margin sits at 49.28%, operating margin at 12.05%, and free cash flow margin at 17.66%. At this level, the portfolio reflects reasonable cost discipline and adequate pricing leverage at the production layer. The operating margin reading is below average, pointing to businesses where scaling costs remain a challenge. Strong free cash flow margins point to businesses with meaningful financial flexibility and limited dependence on external capital. The margin stack is not uniformly strong, which means the portfolio's earnings resilience under adverse conditions is less certain.
Growth & Forward Outlook
On the forward picture: TTM revenue growth of 25.78% reflecting robust top-line expansion across the underlying holdings. Consensus EPS estimates point to 28.0% earnings growth over the next 12 months — a compelling near-term earnings catalyst that, if delivered, changes the valuation conversation materially. Analyst price targets suggest street expectations imply a constructive but measured return profile on a 12-month view. Revenue growth is grounded in reported results; price targets are forward projections that embed assumptions about multiple expansion, earnings delivery, and macro conditions. The key risk in both directions is whether the underlying businesses can maintain their operating trajectory as macro and sector conditions evolve. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyAcross the metrics reviewed, the evidence is consistently constructive — quality, growth, and valuation are pulling in the same direction.
These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.